Skip to main content
SpringerLink
Log in

Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

As clinicopathological features may not be sufficient to predict the progression of thymoma, we have carried out what we believe to be the first immunohistochemical study describing the relationship between the different types of thymoma and the tumour stage, on the one hand, and the expression of epidermal growth factor (EGF), EGF-receptor (EGFR), p53, v-erb B and ras p21, on the other. The positive rates versus histological types and Masaoka's clinical stages in the 47 cases were as follows: p53 (non-invasive thymoma: 41.7%; malignant thymoma category I: 82.4%; malignant thymoma category II: 83.3%), EGF (non-invasive thymoma: 4.2%; malignant thymoma category I: 11.8%; malignant thymoma category II: 33.3%) and EGFR (non-invasive thymoma: 8.3%; malignant thymoma category I: 35.3%; malignant thymoma category II: 66.7%); p53 (stages I and II: 51.7%; stages III and IV: 77.8%), EGF (stages I and II: 3.4%; stages III and IV: 22.2%) and EGFR (stages I and II: 13.8%; stages III and IV: 44.4%). These data suggest that p53 may be implicated in the initial stages of tumorigenesis and that increased expression of EGF and EGFR may play a role in thymoma progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bandyopadhyay SK, D'Andrea E, Fleissner E (1989) Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma. Oncogene Res 4:311–318

    Google Scholar 

  2. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Lane DP (1990) Patterns of expression of the p53 tumour suppressor in human breast tissues in situ and in vitro. Int J Cancer 46:839–844

    Google Scholar 

  3. Bartek J, Iggo R, Gannon J, Lane DP (1990) Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893–899

    Google Scholar 

  4. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703

    CAS  PubMed  Google Scholar 

  5. Bernatz PE, Harrison EG, Clagett OT (1961) Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 42:424–444

    Google Scholar 

  6. Carding S, Reem GH (1987) c-myc gene expression and activation of human thymocytes. Thymus 10:219–229

    Google Scholar 

  7. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D (1988) p53 expression in breast cancer. Int J Cancer 41:178–183

    Google Scholar 

  8. Cho KR, Vogelstein B (1992) Genetic alterations in adenomacarcinoma sequence. Cancer Supplement 70:1727–1731

    Google Scholar 

  9. Christensen ME, Therkildsen MH, Hansen BL, Albeck H, Hansen GN, Bretlau P (1992) Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas. Eur Arch Otorhinolaryngol 249:243–247

    Google Scholar 

  10. Cohen S, Carpenter G (1975) Human epidermis growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA 72:1317–1321

    Google Scholar 

  11. Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79:3637–3640

    Google Scholar 

  12. Fujimori T, Satonaka K, Yamamura-Idei Nagasako K, Maeda S (1994) Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. In J Cancer 57:51–55

    Google Scholar 

  13. Hamburger AW, White CP, Brown RW (1981) Effect of epidermal growth factor on proliferation of human tumor cells in soft agar. J Natl Cancer Inst 67:825–830

    Google Scholar 

  14. Hayashi Y, Widjajati Y, Ohta K, Hanioka K, Obayashi C, Itoh K, Imai Y, Itoh H (1994) Expression of EGF, EGF-receptor, p53, v-erb B, and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues. Pathol Int 44:124–130

    Google Scholar 

  15. Heimann B, Beimling P, Pfaff E, Schaller H, Moelling K (1985) Analysis of a tyrosine-specific protein kinase activity associated with the retroviral erb B oncogene product. Exp Cell Res 161:199–208

    Google Scholar 

  16. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335:675–679

    Google Scholar 

  17. Imazeki F, Omata M, Nose H, Ohto M, Isono K (1992) p53 gene mutations in gastric and esophageal cancers. Gastroenterology 103:892–896

    Google Scholar 

  18. Ishii N, Miyamoto Y, Kiyonari N, Tsubota N, Sakai H, Kusumoto M, Itouji E, Adachi H, Kono M, Obayashi C, Itoh H (1992) Evaluation of surgical treatment of anterior mediastinal malignancies; surgical treatment of thymoma. Jpn J Clin Radiol 37:793–800

    Google Scholar 

  19. Kanai T, Hirohashi S, Noguchi M, Shimosato Y (1987) Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis. Jpn J Cancer Res 78:1314–1318

    Google Scholar 

  20. Kasselberg AG, Orth DN, Gray ME, Stahlman MT (1985) Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem 33:315–322

    Google Scholar 

  21. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80:1337–1341

    Google Scholar 

  22. Kirchner T, Müller-Hermelink HK (1989) New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10:167–189

    Google Scholar 

  23. Kondo K, Mukai K, Sato Y, Matsuno Y, Shimosato Y, Monden Y (1990) An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100β-positive small lymphocytes. Am J Surg Pathol 14:1139–1147

    Google Scholar 

  24. Koshiishi Y, Noguchi M, Nakajima T, Hirohashi S (1989) Immunohistochemical and immunoblot analysis of ras-p21 expression in lung carcinomas. Acta Pathol Jpn 39:643–647

    Google Scholar 

  25. Kuo TT, Lo SK (1993) Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Müller-Hermelink system. Hum Pathol 24:766–771

    Google Scholar 

  26. Kuo TT, Chang JP, Lin FJ, Wu WC, Chang CH (1990) Thymic carcinomas: histopathologic varieties and immunohistochemical study. Am J Surg Pathol 14:24–34

    Google Scholar 

  27. Lattes R (1962) Thymoma and other tumors of the thymus; an analysis of 107 cases. Cancer 15:1224–1260

    Google Scholar 

  28. Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia. A review of current concept. Hum Pathol 9:495–515

    Google Scholar 

  29. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Tayor WF (1987) Thymoma. A clinicopathologic review. Cancer 60:2727–2743

    Google Scholar 

  30. Lumsby G, Carter RL, Gusterson BA (1990) Low incidence of gene activation in human squamous cell carcinomas. Br J Cancer 61:365–368

    Google Scholar 

  31. Marino M, Müller-Hermelink HK (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch [A] 407:119–149

    Google Scholar 

  32. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492

    Google Scholar 

  33. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J (1984) Growth inhibition of human tumor cells in athymic mice by antiepidermal growth factor receptor monoclonal antibodies. Cancer Res 44:1002–1007

    Google Scholar 

  34. Miyamoto H, Harada M, Isobe H, Akita DH, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y (1991) Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Cancer Res 51:6346–6350

    Google Scholar 

  35. Mizuno T, Hashimoto T, Masaoka A (1990) Distribution of fibronectin and laminin in human thymoma. Cancer 65:1367–1374

    Google Scholar 

  36. Mukai K, Sato Y, Hirohashi S, Simosato Y (1990) Expression of ras p21 protein by thymoma. Virchows Arch [B] 59:11–16

    Google Scholar 

  37. Nomori H, Ishihara T, Torikata C (1989) Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis. Cancer 64:1694–1699

    Google Scholar 

  38. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S (1992) p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358–6364

    Google Scholar 

  39. Oku N, Shimada K, Itoh H (1989) Ha-ras oncogene product in human oral squamous cell carcinoma. Kobe J Med Sci 35:277–286

    Google Scholar 

  40. Pescarmona E, Rosati R, Rendina EA, Venuta F, Baroni CD (1992) Well-differentiated thymic carcinoma: a clinico-pathological study. Virchows Arch [A] 420:179–183

    Google Scholar 

  41. Sasano H, Goukon Y, Nishihira T, Nagura H (1992) In situ hybridization and immunohisto-chemistry of p53 tumor suppressor gene in human esophageal cancer. Am J Pathol 141:545–550

    Google Scholar 

  42. Scambia G, Panici PB, Battaglia F, Ferrandina G, Almadori G, Paludetti G, Maurizi M, Mancuso S (1992) Receptors for epidermal growth factor and steroid hormones in primary laryngeal cancer. Cancer 67:1347–1351

    Google Scholar 

  43. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP (1992) Overexpression of p53 protein in basal carcinomas of human skin. Am J Pathol 141:25–29

    Google Scholar 

  44. Slamon DJ, Kernion JB de, Verma IM, Cline MJ (1984) Expression of cellular oncogenes in human malignancies. Science 224:256–262

    Google Scholar 

  45. Sugiyama K, Yonemura Y, Miyazaki I (1989) Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma. Cancer 63:1557–1561

    Google Scholar 

  46. Sustar S, Rosai J (1991) Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67:1025–1032

    Google Scholar 

  47. Taparowsky E, Shimizu K, Goldfarb M, Wigler M (1983) Structure and activation of the human N-ras gene. Cell 34:581–586

    Google Scholar 

  48. Tsukitani K, Takemoto Y, Noda Y, Mori M, Hayashi T, Kato K (1987) Immunohistochemical detection of human epidermal growth factor in submandibular glands and their tumors using a polyclonal antiserum and a monoclonal antibody. Histochemistry 87:293–300

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Pathology, Faculty of Medicine, Kobe University, 7-5-1, Kusunoki-cho, chuo-ku, 650, Kobe, Japan

    Y. Hayashi, C. Obayashi, K. Hanioka, Y. Imai & H. Itoh

  2. Second Department of Surgery, Faculty of Medicine, Kobe University, Kobe, Japan

    N. Ishii

  3. Third Department of Internal Medicine, Faculty of Medicine, Kobe University, Kobe, Japan

    K. Jinnai

Authors
  1. Y. Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Hanioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Itoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Jinnai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayashi, Y., Obayashi, C., Hanioka, K. et al. Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21. Vichows Archiv A Pathol Anat 426, 43–50 (1995). https://doi.org/10.1007/BF00194697

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194697

Key words

Search

Navigation